Forte Biosciences Inc
FBRX
Company Profile
Business description
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
Contact
3060 Pegasus Park Drive
Building 6
DallasTX75247
USAT: +1 310 618-6994
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
14
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,777.30 | 2.50 | 0.03% |
| CAC 40 | 7,615.99 | 78.42 | 1.04% |
| DAX 40 | 23,641.58 | 372.57 | 1.60% |
| Dow JONES (US) | 43,089.02 | 507.24 | 1.19% |
| FTSE 100 | 8,758.99 | 0.95 | 0.01% |
| HKSE | 24,362.73 | 185.66 | 0.77% |
| NASDAQ | 19,912.53 | 281.56 | 1.43% |
| Nikkei 225 | 38,856.14 | 65.58 | 0.17% |
| NZX 50 Index | 12,448.64 | 18.84 | -0.15% |
| S&P 500 | 6,092.18 | 67.01 | 1.11% |
| S&P/ASX 200 | 8,557.00 | 1.50 | 0.02% |
| SSE Composite Index | 3,430.16 | 9.60 | 0.28% |